Aflac Incorporated (NYSE:AFL) shares are expected to touch $70 in the short term. This short term price target has been shared by 10 analysts. However, the standard deviation of short term price estimate has been valued at 2.98. The target price could hit $76 on the higher end and $67 on the lower end.
Many analysts have stated their opinion on the company shares. Keefe Bruyette & Woods downgrades its rating on Aflac Incorporated (NYSE:AFL). The global brokerage major maintains a current price target of $73 per share. Analysts at the Keefe Bruyette & Woods have a current rating of Market Perform on the shares. The shares were previously rated Outperform. The rating by the firm was issued on May 20, 2016. Company shares have received an average consensus rating of Hold for the current week
On the companys insider trading activities, White Teresa L, officer (President, Aflac U.S.) of Aflac Inc, unloaded 8,976 shares at an average price of $69.8 on June 8, 2016. The total amount of the transaction was worth $626,525, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Aflac Incorporated (NYSE:AFL) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.58 points or 0.84% at $68.37 with 1,869,668 shares getting traded. Post opening the session at $68.78, the shares hit an intraday low of $68.29 and an intraday high of $69.07 and the price was in this range throughout the day. The company has a market cap of $28,304 million and the number of outstanding shares have been calculated to be 413,987,030 shares. The 52-week high of Aflac Incorporated (NYSE:AFL) is $70.0874 and the 52-week low is $51.41.
Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflacs insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells insurance products, including products designed to protect individuals from depletion of assets, such as accident, cancer, critical illness/care, hospital intensive care, hospital indemnity, fixed-benefit dental and vision care plans, and loss-of-income products.